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Toxic effects of chlorpyrifos on liver and 




Objective: The present study is aimed to investigate the physiological and 
morphological alterations associated with chlorpyrifos administration in male 
domestic rabbit. Was tested using differed single chlorpyrifos doses ranging 
from 150-550mg/kg of body weight. 
Materials and Methods: The oral LD50 of chlorpyrifos in male domestic rabbit 
was calculated from logarithmic scale and found to be 333 mg/kg body 
weight. A daily dose of 1/10 LD50 chlorpyrifos (33.3 mg/kg body weight) were 
given to the animals under experiment for six weeks. Control animals were 
given distilled water. Blood samples were collected weekly and analyzed.  
Results: The overall mortality rate was 11.1% in chlorpyrifos-treated rabbits 
compared to 2.1% in controls. Clinical signs included diarrhea, disorientation, 
drowsiness and mild tremor. The final body weight was significantly 
decreased in chlorpyrifos-intoxicated rabbits. Serum glucose was significantly 
increased in response to chlorpyrifos administration recording a maximum 
percentage difference of 27.2% in the 3rd week of the experiment. The 
activities of alanine aminotransferase (ALT), aspartate aminotransferase 
(AST), alkaline phosphatase (ALP) and gamma glutamyl transferase (-GT) 
were significantly higher in chlorpyrifos-fed rabbits compared to controls. 
registering maximum percentage differences of 30.2, 37.1, 26.8 and 29.4% 
during the 5th ,3rd ,4th ,6th weeks of the experiment. In contrast, serum 
cholinesterase (ChE) was markedly decreased recording a maximum 
percentage difference of 64.6% during the 4th week of the experiment. Serum 
bilirubin was gradually increased to record a maximum percentage difference 
of 15.2% in the 5th week. Serum urea and creatinine concentrations were 
significantly elevated in response to chlorpyrifos intake displaying maximum 
percentage differences of 43.6% and 26.4% during the 6th and 4th weeks of 
the experiment, respectively. Serum total protein, albumin and globulin were 
significantly decreased upon chlorpyrifos intoxication exhibiting percentage 
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differences of 25.5, 27.3 and 28.2% at 4th, 6th and 6th, respectively. Serum 
calcium was significantly increased in chlorpyrifos-treated rabbits with a 
maximum percentage difference of 16.8% at the 4th week whereas 
phosphorus significantly decreased with a maximum percentage difference of 
14.3% at the 6th week of the experiment. 
Conclusions: Oral daily administration of 1/10 LD50 chlorpyrifos caused 
significant decrease in body weight, serum cholinesterase, total protein, 
albumin, globulin and phosphorous whereas serum glucose, ALT, AST, 
ALP,-GT, bilirubin, urea, creatinine and calcium were significantly increased.   
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  ذكور األرانب المحلیةفي كلیة الكبد و الكلوروبیروفس علي الأثر سمیة 
 المستخلص
  
علي ذكور  الكلوروبیروفس عطاء مبیدإبعد  معرفة التغیرات الفسیولوجیة والمورفولوجیة: اسةھدف الدر
  ملجرام/كجم من وزن الجسم. 550-150كان اختبر بواسطة سم كلوروبیروفس بجرعات بین . األرانب المحلیة
األرانب  كوري ذف LD50قیمة الجرعة النصف ممیتة  اإلحصائيقد بینت الدراسة بعد التحلیل  الخطوات:
/كجم من وزن ملجرام 33.3/كجم من وزن الجسم.أعطیت األرانب جرعة قیمتھا ملجرام 333بواسطة الفم 
بینما المجموعة الضابطة تناولت یومیا لمدة ست أسابیع من الجرعة النصف ممیتة  1/10الجسم و تساوي 
  عینات الدم كانت جمعت أسبوعیا وتم تحلیلھا. الماء.
ظھرت .  %2.1ما الضابطة نبی  وفسبیروالكلورب ٪ في األرانب المعالجة 11.1 عدل الوفیات كان م النتائج:
 بشكل كبیر في وقد انخفض وزن الجسم .خفیفالرعاش الاالرتباك و النعاس و  سریریة كاإلسھال وعالمات 
بشكل وز في الدم زیادة الجلوك لوحظ وقد .خالل األسابیع األخیرة وفسبیروالكلورمعالجة باألرانب ال ذكور
. من التجربة الثالث٪ في األسبوع  27.2نسبة  وفس حیث سجل أعليبیروالكلورب لمعاملةاستجابة  ملحوظ
) وأنزیم AST) و أنزیم األسبارتیت ((ALT حوظ ألنزیمات الكبد ناقل األمین نشاط مل ظھركذلك 
 أعلي نسب بالترتیب لةسجم جة بالمبیدفي المجموعات المعال -GT)( وناقل جاما جلوتامیت )ALP(الفوسفاتیز
الخامس و الثالث و األسبوع ٪ خالل  29.4و  ٪ 26.8، ٪ 37.1، ٪ 30.2حسب جداولھا علي التوالي 
في ) ChE( أستریز الكولین مستوىض اانخفوجد في المقابل  .علي التواليالرابع و السادس  من التجربة
المرارة  زداتا بینماو .من التجربة الرابعخالل األسبوع  ٪  64.6 نسبة  عليبشكل ملحوظ مسجال أالبالزما 
كذلك ھناك زیادة و الخامس من التجربة.٪ في األسبوع  15.2 ةتدریجیا لتسجیل أقصى نسب في البالزما
 عليأ سجلت لألرانب المعاملة بالكلوروبیروفس حیث الدم مصل فيالیوریا و الكریاتینین ملحوظة في تركیز 
خفض وقد ان علي التوالي. من ھذه التجربة  بوع السادس و الرابع٪ خالل األس 26.4 ٪ و 43.6بة نس
بالنسب التالیة  وفسبیروالكلور سمیة مع زیادة اكبیر اانخفاضولین في الدم یلوبجال و البروتین الكلي و األلبومین
 نسبة تادز بینما . السادس و السادس الرابع و األسبوع ٪ في 28.2و  ٪ 27.3، ٪ 25.5 علي الترتیب
سبوع األ٪ في  16.8 أعلي نسبة ةمسجل وفسبیروالكلوربالكالسیوم في الدم بشكل كبیر في األرانب المعالجة 
من  السادس٪ في األسبوع  14.3  أقل نسبة مشكال ل ملحوظبشك الفوسفور انخفضأن في حین  الرابع
  .التجربة
 كبیر نخفاضا الي قد أديLD50 1/10بجرعة م یومیا عن طریق الفوفس بیروكلورمبید  تناول إن  :خاتمةال
و  البروتین الكلي و األلبومینو  )ChE( أستریز الكولین مثل الكبد و الكلیة في وزن الجسم و كذلك أنزیمات
) AST) و أنزیم األسبارتیت (ALTناقل األمین (زاد معدل سكر الجلوكوز و  و الفوسفور في حین لوبولینجال
في  و الكالسیوم الكریاتینینالمرارة و الیوریا و و -GT)( وناقل جاما جلوتامیت )ALP(یزوأنزیم الفوسفات
  .مصل الدم
  
.نباذكر األر –الكلیة  –الكبد  –سمیة  –وفس بیروالكلور الكلمات المفتاحیة :  
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1.1 Overview   
Pesticides are substances or mixture of substances intended for preventing, 
destroying, repelling or mitigating any pest (United States Environmental 
Protection Agency, EPA, 2007). A pesticide may be a chemical substance, 
biological agent (such as a virus or bacterium), antimicrobial, disinfectant or 
device used against any pest. Subclasses of pesticides include: herbicides, 
insecticides, fungicides, rodenticides, pediculicides, and biocides (Gilden et 
al., 2010). 
 
Insecticides are pesticides used in particular against insects. One of the most 
widely used groups of insecticides in the world is organophosphate 
compounds. Chlorpyrifos is an organophosphate insecticide, acaricide and 
miticide used to control foliage and soil-borne insect pests on a variety of food 
and feed crops (EPA, 2002). The most common trade name is Dursban. 
Chlorpyrifos is effective by direct contact, ingestion and inhalation (Tomlin, 
2006). 
 
The toxicological profile of chlorpyrifos demonstrates that, chlorpyrifos like 
other organophosphates, has anticholinesterase activity in all species tested 
(EPA, 2002 and Slotkin et al., 2005a). Inhibition of brain acetylcholinesterase 
(AChE) at synapses by organophosphorus pesticides (OPP) results in 
accumulation of acetylcholine and over activation of acetylcholine receptor at 
neuromuscular junction and in the autonomic and central nervous system. 
This will manifested in convulsions and even tremors leading in severe cases 
to death (Lotti, 2001). 
 
Chlorpyrifos toxicity is predicted from LD50 (a dose that expected to cause 
death in 50% of animals). Acute oral LD50 of chlorpyrifos in rats was estimated 
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to be 135-163, guinea pigs 504, rabbits 1000-2000 mg/kg body weight 
(Tomlin, 2006). However, no previous study assessed the exact or narrow 
range of oral LD50 in male domestic rabbit. Chlorpyrifos is very low in toxicity 
via dermal exposure; the dermal LD50 in rats was estimated at greater than 
2000 mg/kg. Inhalation LC50 (4-6 hours) of chlorpyrifos for rats >0.2 mg/I 
(Tomlin, 2006).  
 
Several studies addressed the toxic effect of chlorpyrifos on the functions of 
several mammalian organs including liver and kidney. Chlorpyrifos was 
reported to alter the level of the marker parameters related to the liver and 
kidneys in rats and mice (Ncibi et al., 2008; Ambali et al., 2010 and 
Mansour and Mossa, 2011). Significant increase in serum alanine 
aminotransferase (ALT), aspartate aminotransferase (AST), alkaline 
phosphatase (ALP), gamma glutamyl transferase (-GT), glucose, bilirubin, 
total protein and creatinine were reported in animals treated with chlorpyrifos 
(Zama  et al., 2005; Ambali et al., 2007 and Salih et al., 2011) whereas 
marked decrease in serum  cholinesterase (ChE) was documented (El-Banna 
et al., 2009). 
 
Pesticides are being used in large amounts in the Gaza Strip where the 
protective measures are poorly followed (Yassin et al., 2002). More than 
544.4 metric tons of pesticides are used yearly in the Gaza strip. The 
insecticide represents 232.5 metric tons of these pesticides, 18.1 metric tons 
of these insecticides are chlorpyrifos (Personal Communication with 
Ministry of Agriculture, Palestinian National Authority, 2012). These 
highly toxic compounds constitute a real threat on humans. The present work 
is intended to investigate chlorpyrifos toxicity in male domestic rabbits. The 
findings can then be extrapolated to human beings to assess the potential 
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1.2 General objective  
The general objective of the present study is to assess the toxic effects of 
chlorpyrifos on liver and kidney of male domestic rabbit. 
 
1.3 Specific objectives  
1. To determine the oral LD50 of chlorpyrifos in male domestic rabbit.  
2. To examine the effect of 1/10 LD50 chlorpyrifos on general health and body 
weight of male domestic rabbit.  
3. To study the effect of 1/10 LD50 chlorpyrifos on serum glucose. 
4. To study the effect of 1/10 LD50 chlorpyrifos on liver function through 
measurement of serum ALT, AST, ALP, -GT, bilirubin and ChE. 
5. To test the effect of 1/10 LD50 chlorpyrifos on kidney function through 
determination of serum urea and creatinine. 
6. To investigate the effect of 1/10 LD50 chlorpyrifos on serum total protein, 
albumin and globulin. 
7. To study the effect of 1/10 LD50 chlorpyrifos on electrolytes, calcium and 
phosphorus.   
 
1.4 Significance  
1. Chlorpyrifos is being extensively used in agriculture in Gaza Strip with lake 
of protective measures. 
2. Studies on chlorpyrifos toxicity on rabbits are limited in the literature.  
3. The results of the present study may be useful to a ware people particularly 














2.1 Definition of pesticide  
A pesticide is any substance or mixture of substances intended for preventing, 
destroying or repelling any pest. Pests can be insects, mice and other 
animals, unwanted plants (weeds), fungi, or microorganisms like bacteria and 
viruses. Though often misunderstood to refer only to insecticides (Kill insects 
and other arthropods), the term pesticide also applies to herbicides (kill weeds 
and other plants that grow where they are not wanted), fungicides (kill fungi 
including blights, mildews, molds, and rusts), Rodenticides (control mice and 
other rodents), and various other substances used to control pests. Under 
United States law, a pesticide is also any substance or mixture of substances 
intended for use as a plant regulator, defoliant or desiccant (EPA, 2006). 
 
2.2 Definition and classification of insecticides 
An insecticide is a pesticide used against insects. They include ovicides and 
larvicides used against the eggs and larvae of insects respectively. 
Insecticides are used in agriculture, medicine, industry and the household. 
The use of insecticides is believed to be one of the major factors behind the 
increase in agricultural productivity in the 20th century (Van Emden and 
Pealall, 1996). Insecticides can be classified according to the type of action 
into organochlorine, organophosphates, carbamates, pyrethroids, 
neonicotinoids, biological insecticides and antifeedants (Brown, 2006). 
 
2.3 Organophosphorus insecticides  
Organophosphorus insecticides are highly toxic compounds containing active 
phosphorus. They are classified into three groups: phosphorothionate group, 
in which phosphorus is bound to three oxygens and one sulfur (the double 
bond). Phosphorothionates include chlorpyrifos, parathion, and 
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tebupirimphos. Compounds in the phosphorodithioate group are like the 
phosphorothionates but with one of the oxygens replaced by sulfur. 
Phosphorodithioates include malathion, disulfoton, azinphos-methyl, 
sulprofos, and dimethoate. The atoms bound to the phosphorus of 
phosphoroamidothiolates are nitrogen, sulfur, and two oxygens; the double 
bond is to oxygen. Examples of phosphoroamidothiolates are acephate and 
methamidophos (Chambers, 1992). 
 
2.4 Chlorpyrifos  
2.4.1 Definition 
Chlorpyrifos [O,O-Diethyl O-3,5,6-trichloropyridin-2-pyridyl phosphorothioate] 
is an organophosphorus insecticide first registered and marketed by Dow 
Chemical Company used  primarily to kill mosquitoes introduced in 1965  
(Cox, 1994; ATSDR, 1997; EPA, 2000; Mitra, 2008 and Mehta, 2009 ). The 
chemical structure of chlorpyrifos is illustrated in (Figure 2.1) (Bennett, 2001; 






Figure 2.1 Chemical structure of chlorpyrifos (Bennett, 2001; Tomlin, 2006 
and abcbirds, 2010). 
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The food and agriculture organization (FAO) and world health organization 
(WHO) classified chlorpyrifos as Class II: moderately toxic (FAO/WHO, 2000). 
It is designed to be effective by direct contact, ingestion, and inhalation. The 
crops with the most intense chlorpyrifos use are cotton, corn, almonds, and 
fruit trees including oranges and apples (National Agricultural Statistics 
Services, NASS, 2011).  
 
2.4.2 Physical and chemical properties of chlorpyrifos  
Chlorpyrifos occurs as colorless crystals with a mild mercaptan odour. The 
principal chemical properties of chlorpyrifos are compiled in (Table 2.1) 
(Windholz, 1998 and Tomlin, 2006). 
 
Table 2.1 Physical and chemical properties of chlorpyrifos (Windholz, 1998 




Molecular weight 350.57 g/mol 
Melting point 41-42 oC 
Solubility in water 0.0014 g/l at 20 oC 
Vapor pressure 1.87 x 10-5 mmHg at 25 oC 
Density 1.64 g/cm3 
 
 
2.4.3 Mechanism of action of chlorpyrifos 
Chlorpyrifos like other organophosphates inhibits acetylcholinesterase activity; 
an enzyme that break down the neurotransmitter acetylcholine on synapses 
and neuromuscular junction. 
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2.4.3.1 Acetylcholine as a neurotransmitter  
Acetylcholine is an important neurotransmitter in both insects and mammals; it 
is released at the nerve synapse in response to a membrane depolarization 
which is the hallmark of nerve transmission. The acetylcholine then binds to a 
protein receptor in the membrane of the nerve synapse (Figure 2.2.A) ( 
Organophosphate pesticides and chlid health, 2007), which then 
opens/alters an ion channel, which in turn causes changes in the fluxes of 
ions (Na+, K+, Ca+, and Cl-) ultimately perpetuating the nerve impulse (Lee 
and Sine, 2005 and Sine and Engel, 2006). There are two types of 
acetylcholine receptors (AChR) that bind acetylcholine and transmit its signal:  
1. Muscarinic receptors (mAChRs): at which muscarine action mimics the 
stimulatory action of acetylcholine on smooth muscle and gland. Muscarinic 
receptors are blocked by atropine. There are five subtypes of muscarinic 
AChRs based on pharmacological activity M1- M5 (Mohamadi et al., 2009).  
2. Nicotinic receptor (nAChRs): which is stimulated by small amount of 
nicotine whereas a large amount of nicotine blocks the receptor. This effect 
mimics the action of acetylcholine on nicotinic receptor. The nicotinic 
acetylcholine receptors are members of a superfamily of ligand-gated ion 
channels (Dani, 2001 and Hogg et al., 2003). Nicotinic receptors subdivided 
into those found in muscle at neuromuscular junctions and those found in 
autonomic ganglia and the central nervous system. 
 
2.4.3.2 Acetylcholinesterase  
As illustrated in (Figure 2.2.B), once acetylcholine makes its action, it is 
subsequently destroyed by acetylcholinesterase, and the membrane returns 
to its normal resting state (Liu and Casida, 1993 and Zwart et al., 1994). 
 
2.4.3.3 Acetylcholinesterase as a target for chlorpyrifos 
Chlorpyrifos binds to acetylcholinesterase enzyme in an irreversible manner 
leading to its inhibition (Figure 2.2.C).  Acetylcholinesterase inhibition at 
synapses results in accumulation of acetylcholine and over activation of 
acetylcholine receptor at neuromuscular junction and in the autonomic and 
central nervous system. This will manifest in convulsions and even tremors 
leading in severe cases to death (Lotti, 2001; Wiener and Hoffman, 2004). 
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   Figure 2.2 Pathophysiology of organophosphorus (chlorpyrifos) pesticide   





2.4.4 Toxicity symptoms of chlorpyrifos poisoning  
Accumulation of acetylcholine at cholinergic synapses as a result of 
acetylcholinesterase inhibition producing a range of clinical manifestations, 
known as the acute cholinergic crisis, headache, restlessness, insomnia, 
anxiety and other non-specific symptoms. The particular clinical feature 
depends on the type of receptors and their location (Eyer, 2003; Eddleston 
et al., 2006; Paudyal, 2008 and Christensen et al., 2009). 
A. Muscarinic receptors: diarrhoea, urinary frequency, intestinal motility, 
miosis, bradycardia, bronchorrhoea and bronchoconstriction, emesis, 
lacrimation, salivation, hypotension and secretory gland stimulation, cardiac 
arrhythmias and bradycardia. 
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B. Nicotinic receptors: fasciculations and muscle weakness, which may 
progress to paralysis and respiratory failure, mydriasis, twitching, cramps, 
tachycardia and hypertension. 
C. Central nervous system: altered level of consciousness, respiratory 
failure and seizures. 
Severe poisoning results in slurred speech, tremors, ataxia, convulsions, 
depression of respiratory and circulatory centers and, eventually, coma and 
death (Cochran et al., 1992). 
 
2.4.5 Metabolism of chlorpyrifos 
Chlorpyrifos is rapidly absorbed in the intestine and transported to the brain 
with oral dosing (Mendrala and Brzak, 1998). The highest tissue 
concentrations were found in the liver and kidney, but chlorpyrifos did not 
bioconcentrate in tissue (Cochran et al., 1992). The metabolic scheme of 
chlorpyrifos is outlined in (Figure 2.3). Chlorpyrifos is bioactivated to 
Chlorpyrifos oxon in the liver through cytochrome P450 mediated 
desulfuration. Chlorpyrifos oxon is subsequently hydrolyzed by A-esterase to 
diethylphosphate and 3,5,6-trichloro-2-pyridinol (TCP), which is the major 
biological metabolite and environmental breakdown product of chlorpyrifos. 
Chlorpyrifos oxon is the active metabolite of chlorpyrifos, and undergoes 
further metabolism by both A- and B-esterase to form diethylphosphate (DEP) 
and TCP, which can undergo phase II sulfation and glucuronidation 
(Timchalk et al., 2007). 
 




Figure 2.3 Metabolic scheme of chlorpyrifos (Timchalk et al., 2007). 
 
 
2.4.6 Excretion of chlorpyrifos 
Chlorpyrifos is excreted primarily through the kidneys in the urine. 
Approximately 70% of an oral dose was excreted in the urine of humans, 
while 90% was excreted in rats (Cochran et al., 1992). The main route of 
excretion in humans, rats and goats was through the urine. Less than 0.1% of 
the dose administered to goats was found in the milk. 
 
2.4.7 Uses of chlorpyrifos 
Chlorpyrifos is effective in controlling cutworms, corn root worms, 
cockroaches, grubs, flea, beetles, flies, termites, fire ants, and lice. It is used 
as an insecticide on grain, cotton field, fruit, nut and vegetable crops, and well 
as on lawns and ornamental plants. It is also registered for direct use on 
sheep and turkeys, for horse site treatment, dog kennels, domestic dwellings, 
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farm buildings, storage bins, and commercial establishments (EXTOXNET, 
1996 and EPA, 2011).  
 
Chlorpyrifos is being extensively used in the Gaza Strip for the control of 
coleoptera, diptera, homoptera and lepidoptera in soil or on foliage in a wide 
range of crops including fruits (strawberries, figs, bananas, vines, apples and 
pears), citrus fruit, vegetables (potatoes, sweet potatoes, tomatoes and 
pepper), flowers (carnations and anemones), palm, alfalfa, cereals, maize, 
sorghum, glasshouse and outdoor ornamentals, mushrooms, turf, and in 
forestry. Also chlorpyrifos is used for control of household pests, mosquitoes 
(larvae and adults) and in animal houses (Ministry of Agriculture, 2012). 
 
2.4.8 Chlorpyrifos toxicity 
 (FAO) and (WHO) classified chlorpyrifos as Class II: moderately toxic 
(FAO/WHO, 2000). A common measure of acute toxicity is the lethal dose 
(LD50). The oral LD50 (Median lethal dose, is a statistically derived single dose 
of a substance that can be expected to cause death in 50 % of animals when 
administered by the oral rout) is expressed in terms of weight of test 
substance per unit weight of test animal mg/kg body weight. Acute oral LD50 
of chlorpyrifos in rats was estimated to be 135-163, guinea pigs 504, rabbits 
1000-2000 mg/kg body weight (Tomlin, 2006). However, no previous study 
assessed the exact or narrow range of oral LD50 in male domestic rabbit. 
Chlorpyrifos is very low in toxicity via dermal exposure; the dermal in LD50 rats 
was estimated at greater than 2000 mg/kg. Inhaiation LD50 (4-6 hours) of 
chlorpyrifos for rats >0.2 mg/I (Tomlin, 2006).  
 
2.4.9 Effects of chlorpyrifos on liver and kidney 
Mohamed et al. (1990) studied the combined effect of chlorpyrifos and 
chlorpyrifos-methyl on Nubian goats. They found that goats dosed orally with 
a 1/1 mixture of chlorpyrifos and chlorpyrifos-methyl at 300 mg/kg body weight 
caused more rapid death and severe changes than in goats dosed with 
insecticide alone at 150 mg/kg. Hepato-renal lesions were accompanied by 
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increases in AST activity and urea concentration and by decreases in total 
serum protein concentration. 
 
Sakai (1990) found that intraperitoneal injection of 20 mg/kg chlorpyrifos in 
rats lowered plasma erythrocyte and brain cholinestrase activity. In addition, 
Pope and Chakraborti (1992) reported dose-related inhibition of both brain 
and plasma cholinesterase activity in neonatal and adult rats exposed to 
sublethal doses of chlorpyifos. Similar dose-related decrease in plasma and 
brain cholinesterase activity was observed on oral administration of 
chlorpyifos to rats at a dose of 1, 3, and 10 mg/kg/day. Inhibition of 
cholinesterase activity was 69, 82, and 93% for plasma and 8, 63, and 86% 
for brain, respectively (Maurissen et al., 2000). 
 
Chloropyrifos was evaluated for its mammalian toxicity in albino rats (Abd-
allah, 1998). Chloropyrifos was administered orally at doses 1/10 and 1/30 
LD50 daily for 30, 60 and 90 days. The body weight gain of the animals was 
significantly reduced. The activity of serum cholinesterase was significantly 
inhibited in all the tested periods. Serum AST, ALT and ALP activities were 
generally increased at all intervals studied. Albumin and total protein 
concentrations were decreased at 30 and 60 days intervals. In addition, 
Timchalk et al. (2002) reported a significant inhibition of plasma 
cholinesterase in male Fisher rats in response to single oral-dose of 0.5-100 
mg/kg chloropyrifos.   
 
Zama et al. (2005) investigated the activities of serum enzymes ALP, AST 
and ALT, and the levels of bilirubin, creatinine and total protein in female rats 
treated with chlorpyrifos. Pregnant rats were treated orally (from the 6th to the 
15th day of gestation) with different doses (1/5, 1/4, 1/3, 1/2, 2/3 LD50) of 
chlorpyrifos. Animals were dissected in the 19th day of gestation, and then 
blood samples were collected for biochemical study. Significant elevation in 
serum AST, ALT, ALP, bilirubin and creatinine has been observed, whereas 
serum total protein was significantly decreased.  
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Ambali et al. (2007) showed a less progressive increase in weight gain and 
significant elevation in serum creatinine and ALP over a ten-week period in 
mice treated with 1/5 LD50 chlorpyrifos compared to controls. El-banna et al. 
(2009) found significant decrease in serum albumin in response to low and 
high doses of chlorpyrifos (1/25 and 1/10 LD50, respectively) for 16 days in 
male albino rats. AST, ALT and ALP activities, and urea and creatinine levels 
were significantly increased. In contrast, the activity of serum cholinesterase 
was significantly decreased. In addition, Wang et al. (2009) reported an 
increase in serum ALT and bilirubin in rats after subchronic exposure to 
chlorpyrifos. 
 
Krishna and Ramachandran (2009) demonstrated an increase in serum 
calcium in wistre rats in response to chlorpyrifos administration at two different 
doses of 1 and 10 ppm.  
 
The effect of exposure of lactating rat to chlorpyrifos was studied (Mansour 
and Mossa, 2010). Chlorpyrifos was orally administered to lactating rats at 
0.01, 1.00 and 1.35 mg/kg body weight from postnatal day 1 (PN1) until day 
20 (PN20) after delivery. Results indicated decreases in body weight and 
increases in relative liver and kidney weights of exposed dams. Significant 
damage to liver was observed via increased plasma levels of AST, ALT 
lactate dehydrogenase (LDH) and -GT in a dose-dependent manner. At two 
high doses of chlorpyrifos (1.00 and 1.35 mg/kg body weight), the lactating 
mothers showed significant decrease in the activity of ChE. At high dose of 
chlorpyrifos (1.35 mg/kg body weight), total protein and uric acid levels were 
significantly increased. Chlorpyrifos caused dose-related histopathological 
changes in liver and kidney of the chlorpyrifos-treated dams.   
 
The effects of chlorpyrifos on biochemical indices in liver and brain of New 
Zealand white rabbits were determined (Solati et al., 2011). Twelve adult 
male rabbits were randomly assigned to two equal groups (n=6; treatment and 
control group). The treatment group received 50 mg/kg body weight 
chlorpyrifos daily during the first week. The daily doses for the second, third, 
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and fourth weeks were 100, 250, and 400 mg/kg body weight, respectively. 
The control group received ethyl alcohol as the solvent of chlorpyrifos during 
the same period. Blood samples were collected on days 0, 7, 14, 21, and 28. 
Results revealed significant increase in the level of ALP, AST, ALT, and 
cholesterol in the serum (p<0.05, p<0.01). Also significant decrease was 
observed in triglyceride and total protein level of the serum in the treatment 
group as compared with the control group (p<0.05).  
 
Heikal et al. (2012a) observed significant reduction in body weight in rats 
treated with single daily oral dose of 1/20 LD50 chlorpyrifos for 28 consecutive 
days. Also significant increase in blood urea nitrogen and serum creatinine 
was found in chlorpyrifos-treated rats. Similarly, Mossa and Abbasy (2012) 
reported significant decrease in body weight gain of foulated chlorpyrifos-
treated rats. Significant increase in serum AST, ALT, uric acid and creatinine 
was recorded.   
 
Tripathi and Srivastav (2012) pointed out that 5 and 10 mg/kg body weight 
chlorpyrifos induced hypophosphatemia and hypercalcemia particularly at 
later intervals of the experiment in male Wistar rats. In addition, Yıldırım et al. 
(2013) found significant increase in serum AST, ALT, uric acid and creatinine. 
Plasma ChE activity was decreased, while LDH, ALT, -GT, and AST 
activities were increased in chlorpyrifos-treated rats (13.5 mg/kg body weight) 
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CHAPTER 3 
MATERIALS AND METHODS 
 
3.1 Experimental animals 
Healthy adult male domestic rabbits weighting 1000±200 mg were used in the 
present study. Animals were left for one week before experimentation to adapt 
to laboratory conditions. Rabbits were kept in metal cages. The dimensions of 
each cage were 100 x 60 x 60 cm. A commercial balanced diet (Anbar) and 
water were provided ad libitum all over the experimental period. 
  
 
3.2 Determination of chlorpyrifos LD50  
A total number of 80 rabbits were used for determination of LD50 of 
chlorpyrifos. Animals were divided into ten groups (8 rabbits/group). A daily 
dose of 1/10 LD50 chlorpyrifos (33.3 mg/kg body weight) were given to the 
animals under experiment for six weeks. The first nine groups (I-IX) were 
administered different single doses of chlorpyrifos ranging from 150 to 550 
mg/kg body weight as follows: 
 
LD50 determination groups Dose (mg/kg body weight) 
Group I 150 
Group II 200 
Group III 250 
Group IV 300 
Group V 350 
Group VI 400 
Group VII 450 
Group VIII 500 
Group IX 550 
Group X control group - 
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The tenth group was served as control group. Chlorpyrifos was given orally 
using a special stomach tube with a smooth tip to protect the interior lining of 
the oral and buccal cavity from injury. The animals were observed for mortality 
during the 48 hour observation period. The LD50 was determined by graphical 
method (Manna et al., 2004). 
 
3.3 Chlorpyrifos toxicity experiments  
A dose of 1/10 of LD50 chlorpyrifos was given orally to assess chlorpyrifos 
toxicity in male domestic rabbit. Animals were divided into two groups: control 
and experimental groups. Control group comprised 48 rabbits (eight rabbits 
were housed in each cage) and experimental group included 36 rabbits (six 
rabbits were housed in each cage). Experimental groups were orally 
administrated chlorpyrifos daily for overall experimental duration of six weeks. 
Control animals were given distilled water. Administration of chlorpyrifos was 
also done by special stomach tube. Blood samples were collected weekly and 
analyzed. Chlorpyrifos was purchased from the Palestinian Ministry of 
Agriculture. 
 
3.4 General health of rabbits  
Dead animals were recorded in order to calculate the percentage of mortality 
each week according to the following equation: 
 
% Mortality =  Number of dead rabbits  × 100 
                       Total number of rabbits 
 
 Clinical symptoms were observed daily by the researcher himself. 
 
3.5 Body weights 
Animals were individually weighed at the beginning and the end of the 
experiment in order to detect any changes in their body weights. A sensitive 
balance (model: ONA-15, made in Istanbul 1997) was used and weights were 
recorded to the nearest gram.  
 
 




3.6. Physiological studies 
3.6.1 Blood sampling and processing 
Animals from both experimental and control groups were decapitated weekly. 
Blood was then collected in centrifuge tubes. The collected blood was allowed 
to clot and then centrifuged at 3000 r.p.m. for 15 minute. Serum samples were 
separated in glass tubes for biochemical assay.   
 
3.6.2 Determination of serum glucose 
Serum glucose was determined by glucose-oxidase procedure (Trinder, 
1969) using Dialab reagent kits. 
  
Principle 
For serum or plasma, couple assay involving both glucose oxidase and  
peroxidase is frequent employed. In the presence of glucose oxidase, glucose 
is oxidized to gluconic acid and hydrogen peroxide. Hydrogen peroxide 
reacts, in the presence of peroxidase, with phenol and 4-aminophenazone to 
form a quinoneimine dye. The intensity of the pink color formed is proportional 
to the glucose concentration. 
 
 
Glucose + O2 + H2O                                   Gluconic acid + H2O2  
 




Reagent Components Concentrations 
Reagent 1 
Monoreagent 






   5 mmol/l 
0.5 mmol/l 
> 10 KU/l 
> 1 KU/l 
Reagent 2 Standard  100 mg/dl 
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Procedure 
1. Pipette into test tubes the following amount as shown in the table below: 
Reagent Blank Std/Cal Sample  
Standard/Cal - 10 μl - 
Sample - - 10 μl 
Reagent 1  1000 μl 1000 μl 1000 μl 
 
2. Mix well and incubate at 37  oC for 10min. or 20min. at 20-25 oC.  
3. Measure the absorbance of sample and std/cal within 60 minutes against 




Glucose [mg/dl] = 
∆A Sample 




3.6.3 Liver enzymes  
3.6.3.1 Determination of alanine aminotransferase 
Serum alanine aminotransferase (ALT) activity was measured by using 
optimized UV-test according to International Federation of Clinical Chemistry 
and Laboratory Medicine (IFCC), according to Guder method (Guder et al., 




L-Alanine + 2-Oxoglutarate   ALT   L-Glutamate + Pyruvate 
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Reagents 
Components  Concentration  
Reagent 1 
  



















85 mmol/l  
 
 1 mmol/l 
 
 
Monoreagent preparation  
Four parts of R1 were mixed with1 part of R2  





Monoreagent  1000 μl  
Sample  100 μl  
 
Mix, read absorbance after 1 minute and start stop watch. Read absorbance 
again 1, 2 and 3 min thereafter at 340 nm. 
 
Calculation  
From absorbance reading calculates ΔA /min and multiply by the 
corresponding factor:  
ΔA /min X factor (1745) = ALT activity [U/l] 
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3.6.3.2 Determination of aspartate aminotransferase 
Serum aspartate aminotransferase (AST) activity was measured by using 
optimized UV-test according to International Federation of Clinical Chemistry 
and Laboratory Medicine (IFCC), according to Thomas (Thomas, 1998) using 
DiaSys reagent kits. 
 
Principle 
L-Aspartate + 2-Oxoglutarate   AST     L-Glutamate + Oxaloacetate  
 







Four parts of R1 were mixed with1 part of R2  




Components  Concentration  
Reagent 1 
  




MDH (Malate dehydrogenase) 
  
LDH (Lactate dehydrogenase)  
 
 




≥ 600 U/l 
  








 12 mmol/l  
 
0.18 mmol/l  




Monoreagent  1000 μl  
Sample  100 μl  
 
Mix, read absorbance was read after 1 min and start stopwatch. Absorbance 
was read again 1, 2 and 3 min thereafter at 340 nm. 
 
Calculation  
From absorbance reading calculates ΔA /min was calculated and multiply by 
the corresponding factor:  
ΔA /min X factor (1745) = AST activity [U/l] 
 
 
3.6.3.3 Determination of alkaline phosphatase  
Serum alkaline phosphatase (ALP) activity was measured by kinetic 
photometric test, according to the International Federation of Clinical 
Chemistry and Laboratory Medicine (IFCC), according to the method 




p-Nitrophenylphosphate + H2O   ALP     phosphate + p-nitroph 
 
Reagents   













1.1 mmol/l  
 
  2 mmol /l 
  
0.5 mmol/l  
 
2.5mmol/l  
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Reagent 2  
p-Nitrophenylphosphate  
 
80 mmol/l  
 
Monoreagent preparation  
Four parts of R1 were mixed with1 part of R2  
(E.g. 20 ml R1 + 5 ml R2) = Monoreagent  
 
Procedure 
 Blank Sample 
Monoreagent  1000 μl 1000 μl  
Sample  -  20 μl  
Dist. water  20 μl -  
 
 
Mix, read absorbance after 1 min and start stopwatch. Read absorbance 
again 1, 2 and 3 min at 405 nm.  
 
Calculation  
From absorbance reading calculates ΔA /min and multiplies by the 
corresponding factor:  
ΔA /min X factor (2757) = ALP activity [U/l] 
  
  
3.6.3.4 Determination of Serum gamma glutamyl transferase 
Serum gamma glutamyl transferase (-GT) is an enzyme present in liver and 
bile duct which is the most sensitive indicator of hepatobiliary diseases. 
Kinetic photometric test according to Szasz method (Szasz, 1969). The test 
has also been standardized to the method according to IFCC (international 
Federation of Clinical Chemistry) (Schumann et al., 2002). Results according 
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 -GT 
to IFCC are obtained using a special factor or, in case a calibrator (TruCal U) 
is used, by use of the calibrator value given for the IFCC method. 
 
Principle 
-GT catalyzes the transfer of glutamic acid to acceptors like glycylglycine in 
this case. This process releases 5-amino-2-nitrobenzoate which can be 
measured at 405 nm. The increase in absorbance at this wavelength is 
directly related to the activity of -GT. 
 

















 Blank Sample 
Sample - 100 μl 
Dist. Water 100 μl - 
Reagent 1 1000 μl 1000 μl 
Reagent 2 250 μl 250 μl 
 
Mix, read absorbance after 2 min and start stop watch. Read absorbance 
again after 1, 2 and 3 minutes. 
 
 




 Blank Sample 
Sample/Calibreate  100 μl 
Dist. Water 100 μl  
Monoreagent 1000 μl 1000 μl 
 
Mix, read absorbance after 2 min and start stop watch. Read absorbance 




From absorbance readings calculate ΔA/min and multiply by the 
corresponding factor from table below: 
 According to Szasz According to IFCC 
Substrate start 405 nm  1421 1606 
Sample start 405 nm 1158 1309 
 
With calibrator 
-GT (U/l) =  ΔA/min Sample  X conc. Calibrator (U/l)  
                     ΔA/min Calibrator 
 
 
3.6.3.5 Determination of cholinesterase activity  
Serum cholinesterase (ChE) activity was measured by kinetic photometric 
test, according to the recommendation of German Society of Clinical 
Chemistry (DGKC), the method described by Ellman and his colleagues 
(Ellman et al., 1961) using DiaSys reagent kits. 
  
Principle  
Cholinesterase hydrolyses butyrylthiocholine under release of butyric acid and 
thiocholine. Thiocholine reduces yellow potassium hexacyanoferrate (III) to 
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colorless potassium hexacyanoferrate (II). The decrease of absorbance is 
measured at 405 nm. 
 
Butyrylthiocholine + H2O   cholinesterase    Thiocholine + Butytate  




Reagent 1  
Pyrophosphate pH 7.6  
Potassium hexacyanoferrate(III)  
 
75 mmol/l  
 2 mmol/l  
Reagent 2  
Butyrylthiocholine  
 




 Reagent /blank  sample 
Sample -  20 μl 
Dist. Water 20 μl  - 
Reagent 1 1000 μl  1000 μl 
Mix, incubate approx.3 min, and then add:  
 Reagent /blank Sample 
Reagent 2 250 μl 250 μl 
 
Mix, read absorbance after 2 min and start stop watch. Read absorbance 
again after 1, 2 and 3 minutes at 405 nm.  
ΔA/min = [ΔA/min Sample] – [ΔA/min Blank]  
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Calculation   
Calculate ΔA/min and multiply with 68500 =cholinesterase activity U/l. 
 
3.6.4 Determination of bilirubin 
Principle 
Both direct and indirect bilirubin couple with diazo in the presence of cetrimide 
(Pearlman and lee, 1974). The terms direct and total refer to the reaction 
characteristics of serum bilirubin in the absence or presence of solubilizing 
(accelerating) reagents. The direct and indirect bilirubin is only approximately 
equivalent to the conjugated and unconjugated fractions. 
 
Reagents 
Working reagent: transfer the contents of one reagent BT vial into a reagent 
AT bottle for total bilirubin determination. Mix thoroughly. Other volumes can 
be prepared in the proportion: 1 ml reagent BT + 4 ml reagent AT. Stable for 
20 days at 2-8 C. 
 
Procedure  






Distilled water 100 μl - - - 
Sample - 100 μl 100 μl - 
Standard(S) - - - 100 μl 
Reagent (AT) - 1.0 μl - - 
Working Reagent 1.0 μl - 1.0 μl 1.0 μl 
 
2- Mix thoroughly and let stand the tubs for 2 min at room temperature. 
3- Read the absorbance (A) of the sample blanks at 540 nm against distilled 
water.  
4- Read the absorbance (A) of the sample and of the stranded at 540 nm 
against the reagent blank. 
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Calculations 
The bilirubin concentration in the sample is calculated using the following 
formula: 
A Sample- A Sample    X C Standard 
         A Standard 
 C Standard = C Sample 
 
 
3.6.5 Non- protein nitrogen constituents  
3.6.5.1 Determination of urea 
Serum urea was determined by using "Urease-GLDH": enzymatic UV test, 
according to Thomas method (Thomas, 1998) using DiaSys reagent kits.  
 
Principle  
Urea + 2H2O   Urease   2NH4+ + 2HCO3-  
 
2-Oxaloglutarate + NH4+ + NADH   GlDH   L-Glutamate +NAD+ +H2O  
 
GLDH: Glutamate dehydrogenase.  
 
Reagents 
Component  Concentration  
Reagent 1:  







   9 mmol/l  
0.75 mmol/l  
≥ 7 KU/l  
≥1 KU/l  
Reagent 2:  
NADH  
 
1.3 mmol/l  
Standard  50 mg /dl (8.33 mmol/l)  
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Monoreagent preparation  
Four parts of R1 were mixed with1 part of R2  




Mix and incubate for 60 sec. at 25 C, then read absorbance A1. After exactly 
further 60 sec. read absorbance A2 at 340 nm.  




Urea [mg/dl] =  Δ  A sample X conc. Std /Cal [mg/dl]  
                           Δ  A std /cal 
 
 
3.6.5.2 Determination of creatinine  
Serum creatinine was determined by using kinetic test without 
deproteinization according to Newman and Price method (Newman and 
Price, 1999) using DiaSys reagent kits. 
 
Principle  
Creatinine forms a colored orange-red complex in an alkaline picrate solution. 
The different in absorbance at fixed time during conversion is proportional to 
the concentration of creatinine in the sample. 
 
Creatinine + picric acid                      Creatinine picrate complex  
 
 Blank Sample or standard 
Sample or standard  -  10 μl  
Monoreagent  1000 μl  1000 μl  
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Reagents  
Concentration  Component  
 
 
0.16 mmol/l  
Reagent 1 
  










Monoreagent preparation  
Four parts of R1 were mixed with 1 part of R2  




 Blank Std./Cal. Sample 
Monoreagent  1000 μl  1000 μl  1000 μl  
Sample  -  -  50 μl  
Std./Cal.  -  50 μl  -  
Dist. water  50 μl  -  -  
 
Mix and read absorbance A1 after 60 sec against reagent blank at 492 nm, 
read absorbance A2 after further 120 sec.  
 
Calculation 
Creatinine concentration [mg/dl] = (Δ A sample) X Conc. Std [mg/dl]  
                                                       (Δ A standard) 
 
ΔA = [(A2 – A1) sample or standard] – [(A2 –A1) Blank]  
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3.6.6 Protein profile  
3.6.6.1 Determination of total protein  
Serum total protein was determined by photometric test according to Thomas 
method (Thomas, 1998) using DiaSys reagent kits. 
 
Principle  
Protein together with copper ions forms a violet blue color complex in alkaline 






Monoreagent preparation  
Four parts of R1 were mixed with1 part of R2  





Components  Concentrations  




Potassium sodium tartrate  
 
 
 80 mmol/l 
  
12.8 mmol/l  

















6 mmol/l  
Standard  5 g/dl 
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Procedure 
 Blank Sample 
Monoreagent  1000 μl  1000 μl  
Sample  -  20 μl  
Dist. water  20 μl  -  
 
 
Mix, incubate for 5 min at 25°C and read absorbance against the reagent 
blank within 60 min at 540 nm.  
 
Calculation  
The protein concentration in the sample is calculated using the following 
general formula: 
Total protein [g/dl] =   (Δ A sample)     X Conc. Std [g/dl]  
                                    (Δ A standard)  
 
3.6.6.2 Determination of albumin 
Serum albumin was determined by photometric test according to the method 
described by Johnson and his colleagues (Johnson et al., 1999) using 
DiaSys reagent kits.  
 
Principle  
Serum albumin in the presence of bromecresol green at a slightly acid pH 
produces a color change of the indicator iron yellow-green to green blue.  
 
Reagents 
Components  Concentrations  
Reagent  
 
Citrate buffer       pH 4.2 
  
Bromocresol green  
 
 




Standard  5g/dl  
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Procedure 
  Blank Sample 
Reagent 1000 μl 1000 μl 
Sample - 10 μl 
Dist. Water 10 μl - 
 
Mix, incubate for approx. 10 min. and read the absorbance against reagent 
blank within 60 min at 540 – 600 nm.  
 
Calculation  
Serum albumin concentration in the sample is calculated using the following 
general formula: 
 
Albumin [g/dl] =   (Δ A Sample)    X Conc. Std [g/dl] 
                             (Δ A Standard) 
 
 
3.6.6.3 Determination of globulin  
Globulin was calculated according the following formula:  






3.6.7.1 Determination of calcium  
Serum calcium was determined by photometric test with cresolphthalein 
complex one (Thomas, 1998) using DiaSys reagent kit. 
 
Principle 
Cresolphthalein complex one reacts with calcium ions in alkaline medium 
forming a red-violet color. Interference by magnesium is eliminated by 
addition of 8-hydroxy-quinoline. 
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Reagents 
Reagent Components Concentrations 
Reagent 1 Ethanolamine Detergent pH 10.7 600 mmol/l 
Reagent 2 
2-Cresolphthalein complex one 
8-Hydroxyquinoline Hydrochloric 
acid pH 1.1 
0.06 mmol/l 
 7 mmol/l 
20 mmol/l 
Reagent 3 Standard:  10 mg/dl 
 
Preparation and stability of working reagent: 
Four parts of R1 were mixed with 1 part of R2 
Stability: 3 days at 2-8 oC 
 
Procedure 
Wavelength  570 nm, Hg 578 nm (550-590 nm) 
Temperature  37°C 
Cuvette  1 cm light path 
Reading against reagent blank was done 


















Mixing and reading the optical density (OD) after a 5 minute incubation was 





  X n =sample calcium concentration(mg/dl)  
OD Standard 
 
n = standard calcium concentration 
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Phosphorus 
3.6.7.2 Determination of phosphorus  
Serum phosphorus was determined by phosphomolybdate UV end point 
(Tietz, 1994) using Amonium Molybdate Diagnostic kit. 
 
Principle 
Determination of inorganic phosphate was made according to the following 
reaction: 
         










Standard Phosphorus  5 mg/dl 
 
Preparation and stability of working reagent: 
The reagent is ready for use 
 
Procedure 
Wavelength  340 nm 
Temperature  37°C 
Cuvette  1 cm light path 
 
Reading against reagent blank was done 
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Mixing and reading the optical density (OD) after a 5 minute incubation was 






  X n =sample Phosphorus concentration(mg/dl)  
OD Standard 
 
n = standard Phosphorus concentration 
 
 
3.7 Statistical analysis 
Data were statistically analyzed using SPSS computer program version 18.0 
for windows (Statistical Package for Social Sciences Inc, Chicago, Illinois). 
Means were compared by independent-sample t-test. 
  
Probability values (P) were obtained from the student's table of "t" and 
significance was at P < 0.05. 
  
The percentage difference was calculated according to the formula: 
Percentage difference equals the absolute value of the change in value, 
divided by the average of the 2 numbers, all multiplied by 100. 
Percent difference = (| (V1 - V2) | / ((V1 + V2)/2)) * 100. 
 
Graphs  
Body weight graph and logarithmic scale of oral LD50 of chlorpyrifos was 











4.1 Oral LD50 of chlorpyrifos 
 
The experimental trials for oral LD50 determination of chlorpyrifos after 48hr of 
administration in male domestic rabbits revealed that the mortality 
commenced at 200 mg/kg body weight, recording mortality percentage of 
12.5% (Table 4.1). Increasing chlorpyrifos dose to 250, 300, 350, 400 and 450 
resulted in mortality percentages of 37.5, 50, 50, 62.5 and 75.0%, 
respectively. The mortality rate was a function of dose increase. The 
maximum concentration of chlorpyrifos which kill all animals in the group was 
found to be 500 mg/kg body weight. The calculated oral LD50 of chlorpyrifos in 
male domestic rabbits from the linear regression was found to be 333 mg/kg 
body weight (Figure 4.1). 
 
Table 4.1 Mortality percentage of male domestic rabbits after 48hr of oral 










Group I  150 0/8 0 
Group II  200 1/8 12.5 
Group III  250 3/8 37.5 
Group IV  300 4/8 50 
Group V  350 4/8 50 
Group VI  400 5/8 62.5 
Group VII  450 6/8 75 
Group VIII  500 8/8 100 
Group IX  550 8/8 100 
Group X  Control 0/8 0 
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The number of animals administered chlorpyrifos was 8 in each group (I to 
IX). Control animals were given distilled water and their number was also 8. 
 
 

























Figure 4.1 Logarithmic scale of oral LD50 of chlorpyrifos in male domestic 
rabbits (LD50=333 mg/kg body weight). 
 
 
4.2 General health of rabbits  
To assess chlorpyrifos toxicity in rabbits, 1/10 LD50 chlorpyrifos (33.3 mg/kg) 
was orally administered daily for 6 weeks. The mortality rate recorded for 1/10 
LD50 chlorpyrifos-treated rabbits was 0/6 (0%), 0/6 (0%), 0/6 (0%),1/6 
(16.7%), 1/6 (16.7%) and 2/6 (33.3%) after 1st, 2nd, 3rd, 4th, 5th and 6th weeks 
of the experiment, respectively. However, only one rabbit died in the control 
group during the 6th week of the experiment recording mortality rate of 1/8 
(12.5%). In addition, rabbits in the control group did not show any sign of 
toxicity. However, chlorpyrifos-fed rabbits showed varying degrees of clinical 
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signs few minutes after dosing. The signs included diarrhea, disorientation, 
drowsiness and mild tremor. Concerning morphological changes, chlorpyrifos-
treated rabbits showed hair loss especially in the fifth and sixth weeks of the 
experiment (Figure 4.2A) whereas control animals did not display such 
change. The livers of dissected rabbits also showed scars of depression in 
response to chlorpyrifos administration (Figure 4.2B) whereas those of the 
control animals showed normal appearance. 
 
                 
Figure 4.2 Morphological effect of 1/10 LD50 of chlorpyrifos (33.3 mg/kg body 
weight) after 6 weeks on hair (A) and liver (B) of male domestic rabbit.  
 
4.3 Final body weight  
(Table 4.2) and (Figure 4.3) illustrate the final body weight of male domestic 
rabbits after 6 weeks of daily oral administration of 1/10 LD50 chlorpyrifos 
(33.3 mg/kg body weight). There was a significant decrease in the body 
weight of chlorpyrifos-treated rabbits compared to controls (816.7±35.8 Vs 
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Table 4.2 Final body weight of male domestic rabbits after 6 weeks of daily 























The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4 Biochemical investigation 
  
4.4.1 Serum glucose 
 
Table 4.3 demonstrates serum glucose levels in control and chlorpyrifos-
treated male domestic rabbits along the experimental period of 6 week 
intervals. The mean values of glucose level in controls were 114.3±2.8, 
117.2±3.6, 113.0±3.9, 118.1±4.0, 114.0 ±3.5 and 115.6±4.2 mg/dl during the 
1st, 2nd, 3rd, 4th, 5th and 6th weeks of the experiment, respectively. Oral 
administration of 1/10 LD50 chlorpyrifos (33.3 mg/kg body weight) daily for 6 
weeks caused general increase in glucose level commencing at the second 
week of the experiment. This increment was significant in the last four weeks 
of the experiment with a maximum percentage difference of 27.2% in the 3rd 
week (t=5.514, P=0.002).  
 
Table 4.3 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on serum 












1 114.3±2.8 110.6±3.0 -3.3 0.922 0.392 
2 117.2±3.6 129.7±3.8 10.1 2.291 0.071 
3 113.0±3.9 148.6±4.9 27.2 5.514 0.002 
4 118.1±4.0 142.0±4.7 18.4 3.746 0.013 
5 114.0±3.5 141.5±4.8 21.5 4.635 0.010 
6 115.6±4.2 138.2±4.6 17.8 3.643 0.022 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.2 Liver enzymes  
 
4.4.2.1 Alanine aminotransferase 
The mean values of serum ALT activity in control and chlorpyrifos-treated 
male domestic rabbits along the experimental period of 6 weeks are 
presented in Table 4.4. The normal enzyme activity was 49.5±1.7, 48.7±2.4, 
49.1±1.6, 49.5±1.7, 51.2±2.3, and 51.0±2.5 U/l at the 1st, 2nd, 3rd, 4th, 5th and 
6th weeks of the experiment, respectively. Upon chlorpyrifos administration, 
ALT activity was increased throughout the experimental periods reaching 
mean values of 55.3±1.8, 54.1±1.9, 57.5±2.3, 66.3±2.8, 69.4±2.7 and 
64.5±2.6 U/l. This increase was significant during the last four weeks of the 
experiment recording the maximum percentage difference of 30.2% in the 5th 
week of the experiment (t=5.053, P=0.007). 
 
 Table 4.4 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on 












1 49.5±1.7 55.3±1.8 11.1 2.305 0.055 
2 48.7±2.4 54.1±1.9 10.5 1.748 0.131 
3 49.1±1.6 57.5±2.3 15.8 2.953 0.026 
4 49.5±1.7 66.3±2.8 29.0 5.537 0.003 
5 51.2±2.3 69.4±2.7 30.2 5.053 0.007 
6 51.0±2.5 64.5±2.6 23.4 3.755 0.020 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.2.2 Aspartate aminotransferase 
Table 4.5 provides mean values of serum AST activity in control and 
chlorpyrifos-fed male domestic rabbits all over the experimental period of 6 
weeks. AST activity registered for control animals were 34.2±1.6, 32.8±1.5, 
33.6±1.4, 34.0±2.0, 33.5±1.7 and 33.1±1.8 U/l at the 1st, 2nd, 3rd, 4th, 5th and 
6th weeks of the experiment, respectively. Feeding of animals with chlorpyrifos 
provoked significant elevation in the enzyme activity throughout the 
experiment exhibiting values of 41.3±2.3, 44.1±2.2, 48.9±2.7, 43.8±2.2, 
42.5±2.4 and 40.7±2.1 U/l. The maximum elevation in the enzyme activity was 
recorded at the 3rd week of the experiment showing percentage difference of 
37.1% (t=4.977, P=0.003). 
 
Table 4.5 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on serum 












1 34.2±1.6 41.3±2.3 18.8 2.417 0.046 
2 32.8±1.5 44.1±2.2 29.4 4.195 0.006 
3 33.6±1.4 48.9±2.7 37.1 4.977 0.003 
4 34.0±2.0 43.8±2.2 25.2 3.343 0.029 
5 33.5±1.7 42.5±2.4 23.7 3.089 0.037 
6 33.1±1.8 40.7±2.1 20.6 2.749 0.040 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.2.3 Alkaline phosphatase 
 
The normal activity of serum ALP of male domestic rabbits were 98.3±3.2, 
97.6±2.8, 103.1±4.0, 96.9±2.5, 98.7±3.0 and 100.2±2.9 U/l at 1st, 2nd, 3rd, 4th, 
5th and 6th weeks of the experiment, respectively Table 4.6. Chlorpyrifos 
intake increased the enzyme activity during the last four weeks of the 
experiment, showing mean values of 112.4±4.1, 126.9±4.5, 123.2±4.3 and 
122.1±3.8 U/l in the 3rd, 4th, 5th and 6th weeks, respectively. The significant 
increment in the enzyme activity started from the 4th week of the experiment 
with maximum percentage difference of 26.8% (t=6.228, P=0.002). 
  
Table 4.6 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on serum 












1 98.3±3.2 96.8±3.7 -1.5 0.280 0.787 
2 97.6±2.8 91.7±1.9 -6.2 1.725 0.135 
3 103.1±4.0 112.4±4.1 8.6 1.569 0.178 
4 96.9±2.5 126.9±4.5 26.8 6.228 0.002 
5 98.7±3.0 123.2±4.3 22.1 4.881 0.005 
6 100.2±2.9 122.1±3.8 19.7 4.519 0.011 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.2.4 Serum gamma glutamyl transferase 
Table 4.7 gives the mean values of serum GT activity in control and 
chlorpyrifos-intoxicated male domestic rabbits all over the experimental period 
of 6 weeks. The normal activity of GT was 6.0±0.28, 5.8±0.25, 5.7±0.27, 
5.9±0.25, 6.1±0.24 and 5.8±0.21 U/l at 1st, 2nd, 3rd, 4th, 5th and 6th weeks of the 
experiment, respectively. Daily oral administration of chlorpyrifos increased 
the enzyme activity throughout the experiment to reach mean values of 
6.9±0.31, 6.9±0.33, 7.0±0.35, 7.6±0.37, 7.6±0.36 and 7.8±0.35 U/l, 
respectively. The maximum increase inGT activity was registered at the end 
of the experiment showing percentage difference of 29.4% (t=4.843, 
P=0.008). 
 
Table 4.7 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on serum 












1 6.0±0.28 6.9±0.31 14.0 2.109 0.073 
2 5.8±0.25 6.9 ±0.33 17.3 2.818 0.037 
3 5.7±0.27 7.0±0.35 20.5 2.931 0.026 
4 5.9±0.25 7.6±0.37 25.2 3.678 0.010 
5 6.1±0.24 7.6±0.36 21.9 3.568 0.023 
6 5.8±0.21 7.8±0.35 29.4 4.843 0.008 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.2.5 Cholinesterase activity 
 
The mean values of serum ChE activity in control and chlorpyrifos-fed rabbits 
are pointed out in Table 4.8. The normal ChE activities in control animals 
were 4540±156, 4603±142, 4782±150, 4519±128, 4811±149 and 4647±141 
U/l during the 1st, 2nd, 3rd, 4th, 5th and 6th weeks of the experiment, 
respectively. Oral administration of the organophosphorus pesticide 
chlorpyrifos provoked a marked significant decrease in the enzyme activity to 
values of 2623±91, 2514±102, 2536±85, 2312±79, 2590±103 and 2605±101 
U/l, respectively. The maximum decrease in the mean ChE activity (2312±79 
U/l) was obtained during the four week of the experiment recording a 
percentage difference of 64.6% (t=14.629, P=0.000). 
  
Table 4.8 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on serum 












1 4540±156 2623±91 -53.5 10.593 0.000 
2 4603±142 2514±102 -58.7 11.943 0.000 
3 4782±150 2536±85 -61.4 13.132 0.000 
4 4519±128 2312±79 -64.6 14.629 0.000 
5 4811±149 2590±103 -60.0 12.231 0.000 
6 4647±141 2605±101 -56.3 11.729 0.000 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.3 Serum bilirubin 
The mean levels of serum bilirubin in control rabbits as well as in rabbits 
received chlorpyrifos daily for 6 weeks are presented in Table 4.9. The normal 
levels of bilirubin in control rabbits were 1.64±0.04, 1.70±0.05, 1.71±0.04, 
1.69±0.02, 1.64±0.03 and 1.72±0.06 mg/dl during the 1st, 2nd, 3rd, 4th, 5th and 
6th weeks of the experiment, respectively. Oral administration of chlorpyrifos 
caused gradual increase in bilirubin level to reach its maximum % difference 
of 15.2 during 5th week of the experiment (t=2.901, P=0.044).   
 
Table 4.9 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on serum 












1 1.64±0.04 1.70±0.06 3.6 0.820 0.439 
2 1.70±0.05 1.79±0.07 5.2 1.083 0.320 
3 1.71±0.04 1.85±0.09 8.0 1.458 0.195 
4 1.69±0.02 1.88±0.11 10.7 2.042 0.097 
5 1.64±0.03 1.91±0.10 15.2 2.901 0.044 
6 1.72±0.06 1.94±0.08 12.0 2.323 0.081 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.4 Non-protein nitrogen constituents  
4.4.4.1 Serum urea 
Table 4.10 presents the mean values of serum urea concentration in control 
and chlorpyrifos-treated male domestic rabbits. Urea concentration in control 
animals exhibited values of 38.7±2.1, 37.4±1.9, 37.5±2.2, 36.6±1.8, 35.8±1.9 
and 37.1±2.3 mg/dl during 1st, 2nd, 3rd, 4th, 5th and 6th weeks of the experiment, 
respectively. Daily feeding of chlorpyrifos caused gradual increase in urea 
concentration all over the experimental intervals examined reaching values of 
43.5±2.6, 43.1±2.3, 45.8±2.5, 49.4±2.4, 54.3±3.1 and 57.8±3.0 mg/dl, 
respectively. This increase in urea concentration became significant during 
the last four weeks and reached its maximum percentage difference of 43.6% 
at the end of the experiment (t=5.611, P=0.002). 
 
  
Table 4.10 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on 












1 38.7±2.1 43.5±2.6 11.7 1.387 0.208 
2 37.4±1.9 43.1±2.3 14.2 1.883 0.109 
3 37.5±2.2 45.8±2.5 19.9 2.487 0.047 
4 36.6±1.8 49.4±2.4 29.8 4.309 0.013 
5 35.8±1.9 54.3±3.1 41.1 5.075 0.007 
6 37.1±2.3 57.8±3.0 43.6 5.611 0.002 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.4.2 Serum creatinine 
The mean values of serum creatinine concentrations in control group of male 
domestic rabbits as well as in animals treated with chlorpyrifos along the 
experimental period of 6 weeks are illustrated in Table 4.11. The normal 
values recorded for creatinine concentrations were 0.63±0.02, 0.65±0.02, 
0.70±0.04, 0.69±0.03, 0.67±0.04, and 0.64±0.02 mg/dl at the 1st, 2nd, 3rd, 4th, 
5th and 6th weeks of the experiment, respectively. Upon chlorpyrifos 
administration, serum creatinine concentration fluctuates across the 
experimental period reaching its maximum value of 0.90±0.07 mg/dl during 
the four week of the experiment with percentage difference of 26.4% (t=3.438, 
P=0.018). 
 
Table 4.11 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on 












1 0.63±0.02 0.69±0.04 9.1 1.385 0.209 
2 0.65±0.02 0.75±0.06 14.3 2.014 0.091 
3 0.70±0.04 0.79±0.05 12.1 1.507 0.183 
4 0.69±0.03 0.90±0.07 26.4 3.438 0.018 
5 0.67±0.04 0.81±0.05 18.9 2.590 0.049 
6 0.64±0.02 0.73±0.04 13.1 2.043 0.096 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.5 Protein profile  
4.4.5.1 Serum total protein  
Table 4.12 indicates the normal values of serum total protein levels in male 
domestic rabbits throughout the experimental period of 6 weeks. These 
values were 6.1±0.28, 5.8±0.23, 5.7±0.19, 6.2±0.25, 6.0±0.26 and 5.9±0.21 
mg/dl during the 1st, 2nd, 3rd, 4th, 5th and 6th weeks of the experiment, 
respectively. Total protein level showed an overt decrease in response to 
chlorpyrifos administration along the experimental periods tested. This 
decrease become significant starting from the 3rd week till the end of 
experiment, recording it’s a maximum % difference of 25.5 at the 4th week of 
the experiment (t=4.291, P=0.013).  
 
Table 4.12 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on 












1 6.1±0.28 5.6±0.21 -8.5 1.450 0.221 
2 5.8±0.23 5.0±0.19 -14.8 2.607 0.060 
3 5.7±0.19 4.7±0.22 -19.2 3.327 0.029 
4 6.2±0.25 4.8±0.20 -25.5 4.291 0.013 
5 6.0±0.26 4.9±0.18 -20.2 3.479 0.025 
6 5.9±0.21 4.7±0.20 -22.6 4.079 0.015 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.5.2 Serum albumin 
The mean concentration of serum albumin in control and chlorpyrifos-treated 
male domestic rabbits are shown in Table 4.13. Albumin concentration in 
control animals exhibited mean values of 3.58±0.11, 3.73±0.13, 4.00±0.20, 
3.66±0.17, 3.78±0.15 and 3.95±0.19 mg/dl at 1st, 2nd, 3rd, 4th, 5th and 6th 
weeks of the experiment, respectively. In general, chlorpyrifos intake resulted 
in progressive significant decrease in albumin concentration recording the 
minimum concentration of 3.00±0.08 mg/dl at the end of the experiment with 
percentage difference of 27.3% (t=4.606 and P=0.010). 
 
Table 4.13 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on 












1 3.58±0.11 3.27±0.14 -9.1 1.661 0.141 
2 3.73±0.13 3.29±0.12 -12.5 2.487 0.047 
3 4.00±0.20 3.21±0.10 -21.9 3.530 0.012 
4 3.66±0.17 3.05±0.08 -18.2 2.845 0.036 
5 3.78±0.15 3.07±0.07 -20.7 4.186 0.014 
6 3.95±0.19 3.00±0.08 -27.3 4.606 0.010 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.5.3 Serum globulin  
Table 4.14 demonstrates the normal values of serum globulin levels in male 
domestic rabbits throughout the experimental period of 6 weeks. These 
values were 2.30±0.11, 2.05±0.09, 1.97±0.10, 2.31±0.13, 2.16±0.12 and 
1.94±0.10 mg/dl during the 1st, 2nd, 3rd, 4th, 5th and 6th weeks of the 
experiment, respectively. Oral administration of chlorpyrifos lowered globulin 
levels to 2.16±0.09, 1.82±0.07, 1.61±0.06, 1.81±0.08, 1.74±0.05, and 
1.46±0.03 mg/dl showing percentage differences of 6.3, 11.9, 20.1, 24.3, 21.5 
and 28.2 % at the weekly intervals of the experiment compared to controls. 
This decrease was significant all over the experimental periods expect for the 
1st and 2nd weeks. 
 
Table 4.14 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on 












1 2.30±0.11 2.16±0.09 -6.3 0.934 0.388 
2 2.05±0.09 1.82±0.07 -11.9 2.054 0.109 
3 1.97±0.10 1.61±0.06 -20.1 3.242 0.032 
4 2.31±0.13 1.81±0.08 -24.3 3.418 0.027 
5 2.16±0.12 1.74±0.05 -21.5 3.285 0.030 
6 1.94±0.10 1.46±0.03 -28.2 4.714 0.009 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.6 Electrolytes 
4.4.6.1 Serum calcium 
The mean serum calcium concentrations in controls and in chlorpyrifos-
received male rabbits are provided in Table 4.15. The normal concentrations 
of calcium were 14.1±0.4, 13.8±0.2, 14.2±0.5, 13.6±0.3, 13.9±0.4 and 
14.0±0.6 mg/dl during the 1st, 2nd, 3rd, 4th, 5th and 6th weeks of the experiment, 
respectively. Upon chlorpyrifos administration, serum concentration of calcium 
fluctuates throughout the experiment registering significant increase during 
the 4th and 5th weeks with percentage differences of 16.8 and 14.2 (t=2.902, 
P=0.034 and t=2.856, P=0.046, respectively). 
 
Table 4.15 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on 












1 14.1±0.4 14.9±0.6 5.5 1.058 0.325 
2 13.8±0.2 15.3±0.7 10.3 1.915 0.104 
3 14.2±0.5 16.0±0.7 11.9 2.090 0.082 
4 13.6±0.3 16.1±1.0 16.8 2.902 0.034 
5 13.9±0.4 16.0±0.6 14.2 2.856 0.046 
6 14.0±0.6 15.8±0.5 12.1 2.413 0.073 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 
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4.4.6.2 Serum phosphorus 
Table 4.16 shows serum phosphorus concentrations in controls as well as in 
chlorpyrifos-fed male rabbits. The mean concentrations of phosphorus in 
control animals were 7.3±0.4, 7.5±0.3, 7.1±0.3, 7.4±0.2, 7.5±0.4 and 7.3±0.3 
mg/dl at the 1st, 2nd, 3rd, 4th, 5th and 6th weeks of the experiment, respectively. 
In chlorpyrifos-treated group of rabbits, serum phosphorus fluctuates along 
the whole experiment displaying significant decrease during the 2nd  and 6th  
weeks with percentage differences of 14.3 and 13.1 (t=2.783, P=0.032 and 
t=2.838, P=0.047, respectively). 
 
Table 4.16 Effect of chlorpyrifos (1/10 LD50, 33.3 mg/kg body weight) on 












1 7.3±0.4 6.9±0.2 -5.6 1.044 0.331 
2 7.5±0.3 6.5±0.2 -14.3 2.783 0.032 
3 7.1±0.3 6.3±0.1 -11.9 2.257 0.065 
4 7.4±0.2 6.7±0.3 -9.8 2.044 0.096 
5 7.5±0.4 6.7±0.1 -11.3 2.248 0.088 
6 7.3±0.3 6.4±0.1 -13.1 2.838 0.047 
The number of animals (n) was 8 in control group and 6 in chlorpyrifos-treated 
animals. All values were expressed as mean±SEM. The level of significance 














The extensive use of different pesticides in agriculture and for public health 
purposes has led to drastic effects in many non-target species including man. 
One of these pesticides is the organophosphorus insecticide chlorpyrifos 
which is effective in controlling cutworms, corn rootworms, cockroaches, 
grubs, flea, beetles, flies, termites, fire ants, and lice. It is used as an 
insecticide on grain, cotton, field, fruit, nut and vegetable crops, and well as 
on lawns and ornamental plants (EPA, 2011). Chlorpyrifos poisoning caused 
an irreversible inhibition of acetylcholinesterase enzyme, resulting in 
accumulation of acetylcholine and over activation of acetylcholine receptor at 
neuromuscular junction and in the autonomic and central nervous system. 
This will manifest in convulsions and even tremors leading in severe cases to 
death (Wiener and Hoffman, 2004; Costa, 2006 and Karami-Mohajeri et 
al., 2013).  
 
Although chlorpyrifos is one of the commonest organophosphorus insecticides 
being used in the agricultural sector in Gaza strip (Yassin et al., 2002 and 
Ministry of Agriculture, 2012), limited data are available on this toxic 
compound. Several cases of organophosphorus poisoning were reported 
among farm workers and children in Gaza strip which mostly result from 
use/misuse of this type of pesticides (Yassin et al., 2002 and EL-Shanty, 
2009). In this context, Tomlin (2006) satisfied by determining a wide range of 
oral LD50 of chlorpyrifos in rabbits. To our knowledge no previous study 
determine the exact oral LD50 of chlorpyrifos in domestic rabbits. Therefore, 
the present work was performed to determine the oral LD50 of chlorpyrifos and 
to investigate its toxicological effect on liver and kidney of male domestic 
rabbits. The findings can then be extrapolated to human beings to assess the 
potential hazards in the human populations due to chlorpyrifos exposure. 
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5.1 General health of rabbits 
The present study demonstrates that treatment of rabbits with 1/10 LD50 
chlorpyrifos induced an overall mortality rate of 11.1% throughout the 6 weeks 
of the experiment. Such mortality was mostly attributed to diarrhea which may 
be related to the cholinergic crisis, a consistent sign in organophosphate 
poisoning. This was in agreement with that found by Akhtar et al. (2009) and 
Heikal et al. (2012a) who observed diarrhea in mature male rats in response 
to chronic exposure of chlorpyrifos. In addition, chlorpyrifos-treated rabbits 
showed hair loss especially in the last two weeks of the experiment. This 
coincided with the significant decrease in protein content observed in the 
present study. The livers of chlorpyrifos-treated rabbits showed scars of 
depressions also in the last two weeks of the experiment which may be due to 
distortion in the liver cells. Chlorpyrifos in known to induce morphological and 
histopathological changes in the liver (Ncibi et al., 2008 and Orabi et al., 
2013).        
 
5.2 Body weight 
As indicated in the current data body weight was significantly decreased in 
chlorpyrifos- supplemented rabbits compared to controls. This finding is in 
agreement with that obtained by Carr et al. (2001) and Ahmad and 
Asmatullah (2007). The reduction in body weight in response to chlorpyrifos 
intake may be a result of the combined action of cholinergic and oxidative 
stress and/or due to increase degradation of lipids and proteins as a direct 
effect of organophosphours compound exposure (Goel et al., 2005; Mansour 
and Mossa, 2010; Mossa et al., 2011 and Heikal et al., 2012a). This 
explanation is supported by the recorded significant decrease in protein 
content in chlorpyrifos-treated rabbits compared to controls.  
 
5.3 Biochemical investigation 
5.3.1 Serum glucose 
Results presented in this study revealed that oral administration of 1/10 LD50 
chlorpyrifos daily for 6 weeks caused general increase in serum glucose 
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levels, which becomes significant in the last four weeks of the experiment. 
This finding is in concurrent with that reported by Krishna and 
Ramachandran (2009); Acker and Nogueira (2012) and Orabi et al. (2013).  
Therefore, glucose homeostasis is affected by chlorpyrifos administration. The 
mechanism by which this organophosphorus insecticide induces 
hyperglycemia may involve one or more mechanisms: 1) reduction in insulin 
secretion as a result of the destructive action of chlorpyrifos on the beta cells 
of Langerehans islets in the pancreas (Gulalp et al., 2007 and Ambali et al., 
2011), 2) impairment in hepatic function due to oxidative changes, which 
reduce liver ability to glycogenesis (Slotkin et al., 2005b and Goel et al., 
2006), 3) stimulation of hepatic gluconeogenesis and glycogenolysis 
(Abdollahi et al., 2004), and 4) activation of the hypothalamus-pituitary-
adrenal (HPA) axis. The activation of HPA axis by organophosphorus causes 
secretion of glucocorticoids from adrenal cortex that in turn increases blood 
glucose by induction of gluconeogenesis pathway (Rahimi and Abdollahi, 
2007).     
 
5.3.2 Liver enzymes and bilirubin 
Data presented in this study showed that the mean levels of serum ALT, AST, 
ALP and -GT in the chlorpyrifos-treated rabbits were significantly higher than 
those in the controls. Such elevation of liver enzymes as a result of 
chlorpyrifos administration was documented by other authors (El-Deeb et al., 
2007; Barakat et al., 2011; Khalifa et al., 2011; Heikal et al., 2013 and 
Kamal El-Denin and Ebrahim, 2013). Liver is the center of biotransformation 
and detoxification of foreign compounds and is the most vulnerable to the 
chemical assaults such as chlorpyrifos poisoning (Mansour and Mossa, 2010 
and Heikal et al., 2012b). Serum ALT, AST and -GT are considered to be 
among the most sensitive markers employed in the diagnosis of hepatotoxicity 
(Akhtar, 2009; Ambali et al., 2011 and Newairy and Abdou, 2013). 
Pesticide exposure causes liver damage and leakage of cytosolic enzymes 
from hepatocytes and other body organs into blood (Ncibi et al., 2008; Heikal 
et al., 2013 and Newairy and Abdou, 2013). Elevation of liver enzymes may 
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also be due to increased gene expression due to long term requirement of 
detoxification of pesticides (Friedman et al., 2003). 
 
In contrast to elevation of transaminases, -GT and ALP, serum ChE activity 
was markedly decreased in chlorpyrifos-treated rabbits compared to controls. 
Such inhibition in ChE in response to organophosphorus chlorpyrifos 
administrated was obtained by Holmes and Sundaram (1992), Shalaby et 
al. (1995), Timchalk et al. (2002), El-banna et al. (2009) and Yıldırım et al. 
(2013). It is known that organophosphorus pesticides such as chlorpyrifos 
cause irreversible inhibition of ChE leading to accumulation of acetylcholine 
and over activation of acetylcholine receptor at neuromuscular junction and in 
the autonomic and central nervous system. This is manifested in convulsions 
and even tremors leading in severe cases to death (Chanda et al., 1997; 
Lassiter et al., 1999 and Lotti, 2001). This result is supported by some 
mortalities and the clinical signs of anticholinestrase action represented in 
diarrhea, disorientation, drowsiness and mild tremor observed in chlorpyrifos-
treated rabbits. 
 
In the present study oral administration of chlorpyrifos caused gradual 
increase in bilirubin level throughout the experiment. Such increase was 
reported previously by Ali and Shakoori (1990), Gotoh et al. (2001), Kazmi 
et al. (2003), Zama et al. (2005) and Wang et al. (2009) in chlorpyrifos-
intoxicated rats. The change in serum bilirubin which is accepted as indicator 
of liver function may provide further evidence on hepatotoxicity induced by the 
organophosphorus insecticide chlorpyrifos (Uchendu et al., 2011 and Heikal 
et al., 2012a).  
 
5.3.3 Kidney function 
The influence of chlorpyrifos on kidney function was assessed through the 
measurement of urea and creatinine. Urea concentration was generally 
increased throughout the whole experiment, and this increment becomes 
significant during the last four weeks of the experiment compared to the 
control. For creatinine this increase was also observed along the whole 
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experiment with significant increments in 4th and 5th weeks of the experiment. 
Such findings are in agreement with that reported in other studies (Burtis and 
Edward, 1994; Ambali et al., 2007; Ambali et al., 2011 and Mossa and 
Abbassy, 2012). A creatinine level raised out of proportion to the urea may 
indicate a pre-renal problem (Delanghe et al., 1989). Urea is formed by the 
liver as an end product of protein breakdown and it is one marker of the 
kidney function (Debra Manzella, 2008). Increase in serum urea observed in 
the present study may be due to 1) impairment in its synthesis as a result of 
impaired hepatic function, 2) disturbance in protein metabolism and 3) 
decrease in its filtration rate in the kidney. The decrease in protein profile 
observed in the present study may support this explanation. Creatinine is 
break-down product of creatine phosphate in muscles, and is usually 
produced at a fairly constant rate by the body. Creatinine is chiefly filtered out 
of the blood by the kidneys (Delanghe et al., 1989). Creatinine has been 
found to be a fairly reliable indicator of kidney function. As the kidneys 
become impaired for any reason, for example in case of chlorpyrifos 
poisoning, the creatinine level in the blood will rise due to poor clearance by 
the kidneys. A rise in blood creatinine level is observed with damage to 
functioning nephrons and impaired renal function (Zama et al., 2007 and 
Ambali et al., 2010). 
 
5.3.4 Protein profile  
As indicated in the present results significant decrease in the levels of total 
protein, albumin and globulin concentrations were found in rabbits treated with 
chlorpyrifos compared to the controls. Similar findings were reported in other 
studies as a result of oral administration of different doses of chlorpyrifos 
(Mohamed et al., 1990; Peeples et al., 2005; Akhtar et al., 2009 and 
Elsharkawy et al., 2013). The reduction in serum protein could be attributed 
to changes in protein and free amino acid metabolism and their synthesis in 
the liver. Also, the protein level suppression may be due to loss of protein 
either by reduce in protein synthesis or increased proteolytic activity or 
degradation (Ncibi et al., 2008 and Shin and Moon, 2010). In addition, the 
observed decrease in serum proteins could be attributed in part to the 
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damaging effect of chlorpyrifos on liver cells, as confirmed by the increase in 
activities of serum AST, ALT and -GT. It was reported that albumin levels are 
decreased in liver disease (Khalifa et al., 2011). A decrease in globulin is 
expected as globulin (mostly γ-globulins) may be consumed in the production 
of antibodies in response to chlorpyrifos administration. 
 
5.3.5 Electrolytes  
The mean serum concentration of calcium showed significant increase in 
chlorpyrifos-intoxicated rabbits. In contrast, serum phosphorus concentration 
was significantly decreased in response to chlorpyrifos treatment. Similar 
results were documented by Krishna and Ramachandran (2009) and Khan 
et al. (2013). This indicates that the organophosphorus insecticide 
chlorpyrifos interferes with calcium and phosphorus homeostasis. 
Hypophosphatemia and hypercalcemia particularly at later intervals of the 
experiment (4th, 6th and 8th weeks) were recorded by Tripathi and Srivastav 
(2012) in male Wistar rats exposed to 5 and 10 mg/kg body weight 
chlorpyrifos. They suggested that exposure to chlorpyrifos may disturb 
parathyroid glands and calcitonin cells and may alter bone mineral 




















1. The calculated oral LD50 of chlorpyrifos in male domestic rabbits from the 
linear regression was found to be 333 mg/kg body weight. 
2. Daily oral administration of 1/10 LD50 chlorpyrifos caused an overall 
mortality rate of 11.1% compared to 2.1% in controls. Clinical signs of 
chlorpyrifo-intoxicated rabbits were diarrhea, disorientation, drowsiness and 
mild tremor.  
3. The final body weight was significantly decreased in chlorpyrifos-treated 
rabbits compared to controls. 
4. Serum glucose was significantly increased in response to chlorpyrifos 
feeding compared to controls.  
5. Liver enzymes ALT, AST, ALP and -GT as well as bilirubin were 
significantly higher in the chlorpyrifos-intoxicated rabbits whereas 
cholinesterase level was markedly decreased compared to the controls.  
6. Urea and creatinine concentrations were significantly increased in response 
to chlorpyrifos administration compared to the controls.  
7. There were significant decreases in total protein, albumin and globulin 
values upon chlorpyrifos intake compared to the controls. 





1. Restriction the use of pesticides in home and farm. 
2. The use of more security, such as biological control and the agricultural           
     cycle. 
3. To stody other parameter.  
4. Further studies are needed.  
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